Test filters | DNDi

News

In the media

Press releases

Publications

Scientific articles

Statements

Stories

Videos

Viewpoints

News

15 Sep 2026

New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D

In the media

14 Sep 2026

Asia on high alert as El Niño threatens new dengue epidemic

In the media

9 Sep 2026

Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements

Swissinfo

Publications

8 Sep 2026

Implementing Article 9.5 of the WHO Pandemic Agreement

In the media

5 Sep 2026

Dengue: un essai clinique mondial pour trouver un traitement

Scientific articles

1 Sep 2026

Analysis of the therapeutic gap for Trypanosoma cruzi infection in Colombia (2012 – 2022)

Memórias do Instituto Oswaldo Cruz

In the media

31 Aug 2026

Mycetoma: The Invisible Disease Beneath India’s Soil

The Scientist

Viewpoints

28 Aug 2026

How a one-day cure could finally eliminate sleeping sickness in Africa

Stories

27 Aug 2026

Drug discovery explained: Moonshot: open science to prepare for pandemics?

In the media

25 Aug 2026

Hunting down the last cases of sleeping sickness

Horizon

Stories

20 Aug 2026

Mycetoma at 10: What recognition made possible

Scientific articles

15 Aug 2026

Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay

International Journal for Parasitology: Drugs and Drug Resistance

Scientific articles

5 Aug 2026

ICH E21: from landmark guidance to specific action for maternal and child health

Scientific articles

3 Aug 2026

A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms

Infectious Diseases and Therapy

Viewpoints

3 Aug 2026

A new chapter for African medical innovation

Nature Africa

In the media

1 Aug 2026

End of painful injections as Kenya set to adopt new 14-day Kala-azar treatment

Daily Nation

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D

Asia on high alert as El Niño threatens new dengue epidemic

Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements

Implementing Article 9.5 of the WHO Pandemic Agreement

Dengue: un essai clinique mondial pour trouver un traitement

Analysis of the therapeutic gap for Trypanosoma cruzi infection in Colombia (2012 – 2022)

Mycetoma: The Invisible Disease Beneath India’s Soil

How a one-day cure could finally eliminate sleeping sickness in Africa

Drug discovery explained: Moonshot: open science to prepare for pandemics?

Hunting down the last cases of sleeping sickness

Mycetoma at 10: What recognition made possible

Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay

ICH E21: from landmark guidance to specific action for maternal and child health

A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms

A new chapter for African medical innovation

End of painful injections as Kenya set to adopt new 14-day Kala-azar treatment

Learn more

Get in touch

Support us

Work with us